|Articles|April 27, 2021
Red Blood Cell Contaminants: Upstream Mitigation for Downstream Success
Author(s)BioIVT
When isolating peripheral blood mononuclear cells (PBMCs) from whole blood, red blood cell (RBC) contamination can have a significant impact on your downstream results. In this white paper, learn the sources of RBC contamination, the downstream impact of RBC contamination and mitigation strategies that will improve your results.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FAQ: What You Need to Know About Agentic AI in Drug Discovery
2
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
5